Abstract
Renal disease
is a major cause of mortality in captive lizards. Captive husbandry and
diet are the most common predisposing causes of chronic renal failure,
typically seen in the adult lizard, while acute renal disease is often
infectious or toxic in nature and appears to be more sporadic. Historical
and clinical presentation can vary and the clinician must often rely on
hematology and biochemistry, urine analysis, radiography, and biopsy for
a definitive diagnosis. Diagnostic and treatment regimes are outlined.
Key words: renal failure,
kidney disease, lizard, squamata, green iguana, radiography, urography,
endoscopy, fluid therapy
Introduction
To appreciate
and understand the problems of renal disease in lizards a few basic anatomical
and physiological peculiarities must be understood [1, 3]. All lizards
are essentially uricotelic, such that their main excretory product of
protein metabolism are salts of uric acid (urates) which are produced
by the liver. Uric acid is largely insoluble which serves to reduce insensible
water losses associated with excretion but does predispose dehydrated
lizards to gout if plasma uric acid levels rise above 1487 µmol/L
[4, 5]. Uric acid is actively secreted via the proximal renal tubules.
The squamate kidney is metanephric in structure, has relatively few nephrons,
lacks a loop of Henle and lacks a renal pelvis. Therefore most reptiles
are virtually unable to concentrate urine of a greater osmolarity than
that of plasma. In addition, mature male lizards may possess sexual segment
proliferation of the distal tubule. This is a pale pink glandular tissue
designed for the production of seminal fluid. Grossly, the kidneys are
dark brown in color, paired, short and broad with few lobes. They are
located in the caudodorsal coelomic cavity or pelvis. In laterally flattened
lizards (e.g., chameleons) the kidneys are located craniodorsal to the
pelvis.
Urine produced by
the kidneys flows down a ureter-like mesonephric duct to the urodeum of
the cloaca, where it then passes into the bladder (if present) or cranially
into the distal colon for storage prior to evacuation. Variable changes
in urine concentration and electrolyte composition can occur within the
bladder or distal colon. This means that bladder urine is not sterile
and may not be a true osmotic/electrolyte representation of renal urine.
A renal portal system is anatomically present but its functional significance
is questionable. Nevertheless all potentially nephrotoxic or renally excreted
drugs should be injected into the cranial part of the lizard.
Clinical Investigation
History and Clinical
Findings
In cases of
acute renal disease, there will usually be very little in the way of historical
evidence. Essentially, the lizard becomes rapidly depressed, lethargic,
anorexic and weak, often with a complete cessation of urate output. The
use of nephrotoxic drugs (e.g., aminoglycosides) or exposure to poisons
or toxins may be inferred from a decent history. Often these animals enjoy
good nutrition and a reasonable level of husbandry. On physical examination,
most acute cases will be of good weight and reasonable body condition.
Dehydration may be evident due to reduced skin elasticity, and pharyngeal
edema may be noticed. The kidneys may or may not be palpable.
In cases of chronic
renal disease, there will often be nutritional (high protein diets, excess
vitamin D3 supplementation) or husbandry factors (low humidity, mild long
term water deprivation) that may indicate potential renal compromise.
Such animals tend to have a history of reduced appetite poor, weight gain
or weight loss, and occasionally owners may notice increased drinking.
They are usually of poor body condition, dehydrated and the kidneys may
or may not be palpable. Unfortunately, most owners miss the initial signs
associated with kidney disease, and so chronic cases will often be presented
as emergencies just like the true acute renal failure case.
A thorough physical
examination is essential but it is often necessary to resort to laboratory
techniques and ancillary diagnostics to make a definitive diagnosis.
Medical Stabilization
The aim must be to stabilize
the patient prior to diagnostic work-up. Take a blood sample for laboratory
investigation prior to initiating i.o. or i.v. fluid therapy at 20-40
ml/kg/d. The provision of a suitable thermal environment must never be
overlooked.
Laboratory
A basic data
base including complete blood count and basic biochemistry is essential
in any reptile presenting with anorexia, depression and lethargy and will
direct the clinician towards further laboratory tests and ancillary diagnostics
(Table 1).
The calcium and phosphorus
ratio is often a reliable indicator of renal disease, and is usually elevated
before any other biochemical parameter. The solubility index is calculated
as the product of Ca (mmol/L) x PO4 (mmol/L), and is normally less than
9. If the solubility index rises above 12 then healthy tissue will start
to mineralize, while between 9 and 12 mineralization of diseased tissue
(kidneys) occurs.
Urine samples, either
freshly voided or obtained by cystocentesis, should be examined. Although
lizard urine is not as clinically useful as mammalian urine, examination
is warranted, particularly if obtained by cystocentesis. Microscopic examination
may reveal blood, a high inflammatory cell presence or renal casts indicating
active infection and acute disease. Normal bladder urine may not be sterile,
but if a culture and sensitivity reveals a profuse growth of a single
organism then that may be significant and worth acting upon.
Diagnostic Imaging
and Endoscopy
Dorsoventral radiographs
are useful in most lizards for assessing kidney size, especially if the
kidneys are enlarged. Radiography will also demonstrate renal stones and/or
soft tissue mineralization. In the laterally compressed lizards a horizontal
beam lateral is more useful. It is important to look for bladder stones,
changes in bone density and also constipation due to renal enlargement.
lntravenous urography can be very usefuI when attempting to identify renal
masses (abscess, neoplasia, calculi), renal and ureteral damage and ureteral
obstructions. A cut-down procedure is made to catheterize a cephalic or
jugular vein, although the author has had some success using an intraosseous
line into the proximal tibia. Then 500 mg/kg of suitable water soluble
iodine compound (Conray 280, 280 mg iodine/ml, May & Baker) is injected
i.v. Or i.o. Radiographs are taken at 0, 5, 15, 30 and 60 min post injection.
Ultrasonography from
the ventral mid line and just caudal to the vent can also be used to assess
gross pathological changes.
There is increasing
interest in the use of MRI (which is superior to CT scanning) but the
limited availability and costs of such imaging techniques makes them practically
obsolete for most clinicians.
The problems facing
the clinician include making a definitive diagnosis, determining if it
is acute or chronic, providing specific therapy and general support, and
providing the owner with a prognosis. To this end the author has found
that renal biopsy represents the most important diagnostic and prognostic
tool when investigating renal disease.
Renal biopsies can
be taken in four ways: major celiotomy approach, cranial tail cut-down
approach, transcutaneous needle biopsy and endoscopic biopsy. The author
prefers endoscopic biopsy because it enables visualization of both kidneys
and ureters via a small laparoscopic (celiotomy) incision and the taking
of 1-4 small biopsies (3 Fr) which are submitted for culture and histology.
In the vast majority of cases biopsy provides the definitive diagnosis
and helps give the owner a prognosis. The site of entry is in the paralumbar
area, with the lizard in lateral recumbency; Air inflation aids visualization.
The author's personal opinion is that as soon as the lizard is hydrated
and stable for anesthesia, endoscopy and biopsy should be attempted.
Treatment
(See Table 2)
Acute renal failure
(ARF):
The aim is to keep the
lizard alive until sufficient healing has taken place. If reversed, the
chance for a complete recovery does exist. Initially an accurate weight
is essential as is an accurate assessment of hydration status based on
packed cell volume (PCV) and plasma total protein. Rehydration using 0.18%
saline + 4% glucose is recommended at 20-40 ml/kg/d i.v. Or i.o. Hartmann's
solution may be less appropriate in cases of hyperkalemia (>8 mmol/L).
The author assumes that there may be severe acidosis during acute renal
failure. However, not having the laboratory equipment available to measure
acid-base balance, the author prefers to ignore acid-base disturbances
on the basis that if renal perfusion and function can be restored then
the kidneys will correct the acidosis.
Hydration status should
be monitored using serial weight and PCV measurements. When correct hydration
has been achieved, it is vital that over hydration is avoided and therefore
a reduction in maintenance fluids to 2-10 ml/kg/d is required but hydration
status must continue to be monitored. If over hydration does occur (pharyngeal
edema, pulmonary edema) then the use of diuretics is advisable (furosemide,
thiazides).
In cases where uric
acid levels are significantly elevated (>750 mmol/l) the use of allopurinol
(20 mg/kg p.o. q 24 hr) may reduce hepatic uric acid production, while
the administration of anabolic steroids may reduce protein catabolism.
In cases of pre-renal ARF, rehydration, restoration of circulatory volume
and supportive therapy may be all that is necessary. In cases of post
renal obstruction, renal stones and ureteral obstructions will often have
to be surgically removed before urine flow can be reestablished. In cases
of toxin induced nephropathy, identification and removal of the toxin
from the environment and gastric lavage may be useful. In cases of suspected
aminoglycoside toxicity all drug medication should stop and osmotic diuresis
instigated to maintain renal perfusion once normal hydration status has
been achieved. Acute hypercalcemia (from acute vitamin D3 overdose but
not breeding females) can cause ischemic acute tubular necrosis through
the development of nephrocalcinosis, and in such cases prednisolone, calcitonin
and diuresis should be considered. Chronic renal damage can also lead
to calcium salt deposition in soft tissues including the kidney due to
an elevation in the solubility index. Acute renal disease due to infectious
agents should be empirically treated with broad spectrum anti microbials
until culture and sensitivity results are obtained. It is important to
use drugs with a large safety margin as drug metabolism and excretion
may be significantly affected.
If the lizard remains
oliguric once hydration and any underlying causes have been addressed,
then the i.v. Or i.o. administration of 20% dextrose may be used in an
attempt to induce diuresis. Initially dextrose is given at 0.4-1.0 mI/kg/hr
i.v. Or i.o. for 30-60 min, then the rate is reduced to 0.2-0.5 MI/kg/hr.
If the lizard remains oliguric, then diuretics and coelomic dialysis may
be attempted. The right lateral coelomic region just cranial to the right
limb is prepared aseptically and a 18-23 g 25-50 mm Teflon catheter is
introduced into the coelomic cavity and sutured to the skin. Warm (30-35
C) fluids (30-40 ml/kg) are injected into the coelomic cavity and left
in situ for 1-2 hr before being removed. Balanced electrolyte and hypertonic
5% dextrose solutions are recommended, however due the relative insolubility
of uric acid compared to urea, dialysis appears to be less effective in
reptiles than mammals.
(From January 1995
to January 1996, the author has treated 11 cases of acute renal failure
in lizards, 7 cases (64%) are known to have survived for longer than a
year.)
Chronic renal failure
(CRF):
Unfortunately, most cases
of CRF present as acute emergencies because the owners have missed the
early signs of disease. Essentially, the aim of therapy is two fold. First,
stabilize the patient in much the same way as for acute renal failure,
diagnose the cause of the renal disease (neoplasia, abscessation, tubulonephrosis),
and perform specific therapies including surgery to resolve any immediate
crisis. Then, in the long term, instigate ongoing therapy to reduce further
renal compromise. These long term measures include:
Reducing the protein
intake of the diet. Herbivorous lizards should not be given any animal
or insect protein. Carnivorous tegus and monitors should be offered
less higher quality protein (e.g., whole minced chicken, whole minced
white fish, Hill's a/d diet). Insectivorous lizards should be offered
lower protein insects such as mealworms and earthworms, avoiding the
higher protein locusts. lf however, weight loss ensues due to protein-losing
nephropathy then an increase in dietary protein may be required. Long
term allopurinol therapy may be used to reduce uric acid production.
Reducing hyperphosphatemia
using phosphate binders (aluminum hydroxide) and cimetidine (in cases
of constipation). In cases of hyperphosphatemic tetany (>8 mmol/L),
diuresis is required.
Correcting the hypocalcemia
once plasma phosphorus levels have been reduced to below 2.5 mmol/L
or the solubility index is below 9. Failure to control hyperphosphatemia
prior to calcium therapy will elevate the solubility index and may cause
soft tissue mineralization. Hypocalcemic tetany occurs as calcium levels
fall below 0.8 mmol/L. Correction is achieved by the slow intravenous
infusion of calcium to effect. Oral calcium supplements (such as Neo-Calglucon
and Nutrobal) are useful for long term calcium therapy but the benefit
of vitamin D3 therapy must be weighed against the dangers of iatrogenic
hypercalcemia and soft tissue mineralization. The use of full spectrum
light sources (e.g., Zoo Med Reptisun 5.0 or Iguana light) or better
still sunlight is safer. Monitor Ca:P ratios on a regular basis.
Preventing dehydration
by maintaining humidity and adding water to food items.
Considering anabolic
steroids and vitamin B complex every 7-28 d.
Avoiding nephrotoxic
drugs and undue stress (proper husbandry) to the lizard.
(From January 1995
to January 1996, the author has treated 23 cases of chronic renal failure
in lizards, 5 cases (22%) are known to have survived for longer than a
year.)
If, as clinicians,
we fail to resolve acute renal failure or permit chronic renal disease
to progress unhindered then the outcome will be gout (visceral and articular).
Acute gouty episodes may be treated symptomatically but widespread visceral
gout is the result of end stage kidney disease and the prognosis is usually
hopeless [4].
Literature Cited
1. Barten, S.L. (1996).
Lizards. In: Reptile Medicine and Surg&y (Ed. D.R. Mader), p 47-61.
WB Saunders, Philadelphia.
2. Divers, S.J., Redmayne,
G. and Aves, E.K. (1996). Hematological and biochemical values of 10 green
iguana (Iguana iguana). Veterinary Record 138:203-205.
3. Frye, F.L (1991).
Comparative histology. In: Biomedical and Surgical Aspects of Captive
Reptile Husbandry (Ed. FL Frye), p 488-501. Krieger, Malabar.
4. Mader, D.L. (1996).
Gout. In: Reptile Medicine and Surgery (Ed. DR Mader), p 374-379. WB Saunders,
Philadelphia. 5. Zwart, P. (1992). Urogenital systern. In: Manual of Reptiles
(Eds. P.H. Beynon, M.P.C. Lawton and J.E. Cooper), p 117-120. BSAVA, Cheltenham.
TABLE
1 Blood
Parameters in Iguana iguana Used in the Assessment of Renal Disease
Blood Parameter
|
Normal Range2
|
Diagnostic
use
|
Total WBC (x109/L)
|
3.00-10.00
|
Raised during
inflammation and infection, may be depressed or low during hibernation/post-hibernation
|
Heterophils
(x109/L)
|
0.35-5.20
|
Classic reptile
inflammatory cell, usually raised in sepsis and necrosis
|
Lymphocytes
(x109/L)
|
0.50-5.50
|
Highly variable
but may be elevated in cases of viral disease
|
Azurophils
(x109/L)
|
0.00-1.70
|
Elevated during
bacterial infections and necrosis
|
Monocytes (x109/L)
|
0.00-0.10
|
Elevated in
cases of chronic disease and chronic immunogenic stimulation
|
Eosinophils
(x109/L)
|
0.00-0.30
|
Variable in
number, elevated in protozoa and helminth infections
|
PCV (L/L)
|
0.25-0.35
|
Useful to assess
hydration status, anemia
|
RBC (x1012/L)
|
1.00-1.90
|
Decreased in
cases of chronic disease
|
Hb (g/dl)
|
6.00-10.0
|
Decreased in
cases of chronic disease
|
Urea
|
0.0-0.7
|
Production
and excretion highly variable, may have some limited use as a
guide to early dehydration but not considered clinically reliable
|
Creatinine
|
42-80
|
Limited and
variable production, not reliable
|
Uric acid
|
70-140
|
Raised during
dehydration and with renal disease >70% affected by nutrition
and hepatic disease
|
Creatine
|
n/a
|
More sensitive
but, like uric acid, still rises late in the course of renal disease
|
Calcium (mmol/L)
|
2.2-3.5
|
Affected by
nutrition/UVB/vitamin D, albumin level, decreased during chronic
renal disease but elevated levels cause renal disease
|
Phosphorus
(mmol/L)
|
1.5-3.0
|
Affected by
nutrition/UVB/vitamin D, increased during renal disease
|
Sodium (mmol/L)
|
134-164
|
May be normal
or decreased during renal disease
|
Chloride (mmol/L)
|
106-134
|
|
Potassium (mmol/L)
|
3.4-7.5
|
Often elevated,
especially in acute renal failure
|
Please note that the
normal values refer to the green iguana, and that these ranges will vary
with species, gender, nutrition, environment, season, and reproductive
status.
TABLE
2: Drugs Commonly Used in the Diagnosis and Treatment of Renal
Disease
Drug
|
Dose
|
Comments
|
Allopurinol
|
10-20 mg/kg
p.o. q 24 hr
|
Gout; reduces
uric acid production
|
Calcitonin
|
1.5 lU/kg
s.c. q 8 hr
|
HypercaIcemia;
advice fluids for 50 lU/kg i.m. once, repeat in 2 wk diuresis;
recent studies indicated more frequent dosing required
|
Calcium gluconate
|
100 mg/kg
i.m. q 6 hr
10-20 mg/kg/hr
i.v., i.o. to effect
|
Hypocalcemia;
care of high phosphorus causing high tissue mineralization
|
Neo-Calglucon
Nutrobal
(VetArk)
|
1 ml/kg q
24 hr p.o.
1 g/kg q
24 hr on food
|
Oral calcium
supplement
|
Cimetidine
|
4 mg/kg p.o.
q 8-12 hr
|
Gastric motility
modifier
|
Furosemide
|
2-5 mg/kg
i.m., i.v. q 12-24 hr
|
Diuretic;
beware of dehydration
|
Hydrochlorothiazide
|
1 mg/kg q
2-72 hr
|
Thiazide
diuretic used to promote diuresis; beware of dehydration
|
Prednisolone
|
5-10 mg/kg
i.m., i.v., i.o. as required
0.5-1.0 mg/kg
s.c., i.m., p.o. q 24-48 hr
|
Shock; may
help reduce nephrocalcinosis
|
Vitamin B12
|
0.05 mg/kg
i.m., s.c.
|
Appetite
stimulant
|
Vitamin B
complex
|
0.1 MI/kg
i.m.
|
May aid renal
function and offset renal vitamin losses
|
Vitamin D3
|
1000 lU/kg
i.m., repeat in 7 d
|
Hypocalcemia;
beware of overdose causing hypercalcemia
|
Nandrolone
|
1 mg/kg i.m.
q 7-28 d
|
Anabolic
steroid; reduces protein catabolism
|
Ceftazidime
|
20-40 mg/kg
i.m. q 72 hr
|
Reconstituted
solution viable for 12 hr at +40C or 4 mo if frozen; broad spectrum
|
Enrofloxacin
|
10 mg/kg
i.m., p.o. q 24 hr
|
Broad spectrum
antimicrobial
|
Conray 280
|
500mg/kg
i.v.
|
Intravenous
urography
|
Please see the Glossary
if you need some help with the terminology and abbreviations.
|